Overview

Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Korea Health Industry Development Institute
Treatments:
Methylphenidate